Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Manage your formulary budget
Find generic entry opportunities
Proactively manage your pharmacy inventory
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Use of thiazolidinedione derivatives in the treatment of insulin resistance|
|Abstract:||The present invention provides methods of using thiazolidinedione in the treatment of insulin resistance.|
|Inventor(s):||Antonucci; Tammy (Thousand Oaks, CA), Lockwood; Dean (Ann Arbor, MI), Norris; Rebecca (Kewadin, MI)|
|Assignee:||Warner-Lambert Company (Morris Plains, NJ)|
Patent Claim Types:|
see list of patent claims
Field: Not categorized
Back Citations: 1st percentile
Forward Citations: 0th percentile
|Patent Number||Expiration Date|
|6,046,202||April 04, 2008|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Austria||198045||<disabled in preview>|
|Austria||303147||<disabled in preview>|
|Austria||376829||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.